These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12399203)

  • 1. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand.
    Lolekha S; Warachit B; Hirunyachote A; Bowonkiratikachorn P; West DJ; Poerschke G
    Vaccine; 2002 Nov; 20(31-32):3739-43. PubMed ID: 12399203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
    Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants.
    Milne A; West DJ; Chinh DV; Moyes CD; Poerschke G
    J Med Virol; 2002 Jul; 67(3):327-33. PubMed ID: 12116022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure.
    Wang C; Wang C; Jia ZF; Wu X; Wen SM; Kong F; Hu KQ; Li J; Jiang J; Niu JQ
    Medicine (Baltimore); 2016 Aug; 95(34):e4390. PubMed ID: 27559947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Lu Y; Liang XF; Wang FZ; Yan L; Li RC; Li YP; Zhu FC; Zhai XJ; Li J; Zhuang H
    Vaccine; 2017 Jan; 35(1):40-45. PubMed ID: 27894717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission.
    Zhang L; Gui X; Wang B; Ji H; Yisilafu R; Li F; Zhou Y; Zhang L; Zhang H; Liu X
    Eur J Pediatr; 2014 Sep; 173(9):1161-8. PubMed ID: 24699981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
    Pongpipat D; Suvatte V; Assateerawatts A
    Asian Pac J Allergy Immunol; 1986 Jun; 4(1):33-6. PubMed ID: 3730058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy.
    Xiao XM; Li AZ; Chen X; Zhu YK; Miao J
    Int J Gynaecol Obstet; 2007 Mar; 96(3):167-70. PubMed ID: 17296201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.
    Wang Z; Zhang J; Yang H; Li X; Wen S; Guo Y; Sun J; Hou J
    J Med Virol; 2003 Nov; 71(3):360-6. PubMed ID: 12966540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.
    Ip HM; Lelie PN; Wong VC; Kuhns MC; Reesink HW
    Lancet; 1989 Feb; 1(8635):406-10. PubMed ID: 2563788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abstract efficacy of combined vaccine for the prevention of HBV transmission in highly viremic HBeAg+ mothers and the HBV markers' dynamic change of babies in follow-up].
    Jiang HX; Han GR; Wang CM; Yue X; Wang GJ
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):818-22. PubMed ID: 22433302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area.
    Esteban JI; Genesca J; Esteban R; Hernandez JM; Seijo G; Buti M; Muniz R; Guardia J
    J Med Virol; 1986 Apr; 18(4):381-91. PubMed ID: 2940334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R; Garland S; Wright M; Bulotsky M; Liss C; Lakkis H; Nikas A; Straus W
    Pediatr Infect Dis J; 2009 Sep; 28(9):777-81. PubMed ID: 19636283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of perinatal transmission of hepatitis B virus (HBV): a comparison of two prophylactic schedules.
    Wheeley SM; Jackson PT; Boxall EH; Tarlow MJ; Gatrad AR; Anderson J; Bissenden J
    J Med Virol; 1991 Nov; 35(3):212-5. PubMed ID: 1839553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.